Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation

The origin of CD4+ T cells reappearing in the blood following antiretroviral therapy in human immunodeficiency virus type-1 (HIV-1) infection is still controversial. Here we show, using mathematical modeling, that redistribution of T cells to the blood can explain the striking correlation between the initial CD4+ and CD8+ memory T-cell repopulation and the observation that 3 weeks after the start of treatment memory CD4+ T-cell numbers reach a plateau. The increase in CD4+ T cells following therapy most likely is a composite of initial redistribution, accompanied by a continuous slow repopulation with newly produced naive T cells.

[1]  A. Mocroft,et al.  Antiviral therapy , 1995, Nature.

[2]  J. Giorgi.  Phenotype and Function of T Cells in HIV Disease , 1996 .

[3]  M. Bukrinsky,et al.  Other approaches , 1995, Nature.

[4]  L. Picker,et al.  Lymphocyte Homing and Homeostasis , 1996, Science.

[5]  S. Hammer,et al.  The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. , 1996, The New England journal of medicine.

[6]  Alan S. Perelson,et al.  Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.

[7]  M. Roos,et al.  Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudine. , 1993, The Journal of infectious diseases.

[8]  S. Hammer,et al.  A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. , 1996, The New England journal of medicine.

[9]  J Leibowitch,et al.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. , 1997, Science.

[10]  H. Clifford Lane,et al.  HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies , 1997, Nature Medicine.

[11]  J. Sprent,et al.  CD4+ cell turnover , 1995, Nature.

[12]  R. Zinkernagel,et al.  Immunological Memory , 2006 .

[13]  D. Cooper,et al.  Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. , 1996, The Journal of infectious diseases.

[14]  J. Sprent,et al.  Viruses and T Cell Turnover: Evidence for Bystander Proliferation , 1996, Immunological reviews.

[15]  L. Sabatier,et al.  Immunosenescence in HIV pathogenesis. , 1997, Virology.

[16]  David Gray,et al.  Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.

[17]  M. Roos,et al.  T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. , 1995, The Journal of infectious diseases.

[18]  S. Steinberg,et al.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.

[19]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[20]  D. Monos,et al.  Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: implications for T cell proliferation in HIV disease. , 1997, The Journal of clinical investigation.

[21]  H. Grosse-wilde,et al.  Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. , 1996, Blood.

[22]  C. Polman,et al.  Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. , 1997, The Journal of clinical investigation.

[23]  Anthony S. Fauci,et al.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.

[24]  J. Darbyshire,et al.  Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals , 1996, The Lancet.

[25]  E. Bloemena,et al.  Whole-blood lymphocyte cultures. , 1989, Journal of immunological methods.

[26]  R. Pabst,et al.  Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? , 1990, Immunology today.

[27]  B L Levine,et al.  Human naive and memory T lymphocytes differ in telomeric length and replicative potential. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Niels Schaft,et al.  T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4+ T Cell Turnover , 1996, Science.

[29]  M. Zupancic,et al.  Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. , 1997, Science.

[30]  C. Tamalet,et al.  Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma. , 1996, The Journal of infectious diseases.

[31]  J. Leonard,et al.  Decrease of HIV‐1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine , 1998, AIDS.

[32]  P. Hartigan,et al.  Changes in Plasma HIV RNA Levels and CD4+ Lymphocyte Counts Predict Both Response to Antiretroviral Therapy and Therapeutic Failure , 1997, Annals of Internal Medicine.

[33]  P. Reiss,et al.  Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[34]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[35]  J. Veenstra,et al.  The predictive value of T cell function in vitro and pre-AIDS zidovudine use for survival after AIDS diagnosis in a cohort of homosexual men in Amsterdam. , 1995, The Journal of infectious diseases.

[36]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[37]  M. Roederer,et al.  CD8 naive T cell counts decrease progressively in HIV-infected adults. , 1995, The Journal of clinical investigation.

[38]  H. Lane,et al.  Telomere Length, Telomerase Activity, and Replicative Potential in HIV Infection: Analysis of CD4+ and CD8+T Cells from HIV-discordant Monozygotic Twins , 1997, The Journal of experimental medicine.

[39]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[40]  M. Cloyd,et al.  HIV induces homing of resting T lymphocytes to lymph nodes. , 1997, Virology.

[41]  L. Picker,et al.  Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. , 1993, Journal of immunology.

[42]  D. Mosier.  CD4+ cell turnover , 1995, Nature.